Interrater agreement of the classification of phlebitis, its signs, and symptoms in peripheral intravenous catheters

Authors

DOI: https://doi.org/10.6018/eglobal.659521
Keywords: Observer Variation, Reproducibility of Results, Phlebitis, Signs and symptoms, Catheters, Cohort studies

Abstract

Introduction: Although various tools for assessing the presence and severity of complications associated with CVPs have been described in the literature, standardised guidelines are still lacking and further research is required.

Objetive: The objective of this study was to determine inter-rater agreement for the classification of phlebitis, its signs, and symptoms using the Visual Infusion Phlebitis Scale.

Material and methods: This was a prospective cohort study of patients aged 18 years and older hospitalized in an emergency department with their first peripheral venous catheter in place. Signs and symptoms of phlebitis were assessed daily using the scale. A descriptive analysis was performed, and agreement for the classification of phlebitis, its signs, and symptoms was calculated using Cohen's Kappa coefficient.

Results: 817 patients were included. The most common sign or symptom was erythema (13.59%), followed by pain (11.50%), edema (2.99%), and induration (2.02%). There was no palpable venous cord or pyrexia. The overall incidence of phlebitis was 11.44%; grade II (9.42%) and grade III (2.02%). Cohen's Kappa coefficient was 0.990 (95% CI 0.982–0.996) for the general classification of phlebitis. The highest reproducibility for signs and symptoms was pain (k=0.946), followed by induration (k=0.894), edema (k=0.716), and erythema (k=0.649).

Conclusions: This study showed high inter-rater agreement overall for the scale and good to very good agreement for each sign and symptom.

Downloads

Download data is not yet available.
Metrics
Views/Downloads
  • Abstract
    6
  • ESP_PDF (Español (España))
    0
  • ENG_PDF
    0

Author Biographies

Lyda Z. Rojas, Universidad Industrial de Santander. Facultad de Salud, Escuela de Enfermería

PhD. Professional Nurse with a master’s degree in Epidemiology and a PhD in Biomedical Research and Public Health. Universidad Industrial de Santander, Facultad de Salud, Escuela de Enfermería. Bucaramanga, Colombia. Centro de Investigación, Fundación Cardiovascular de Colombia, Floridablanca, Colombia

Fabio Alberto Camargo-Figuera, Universidad Industrial de Santander. Facultad de Salud, Escuela de Enfermería

PhD. Professional Nurse with a master’s degree and a PhD in Epidemiology. Universidad Industrial de Santander, Facultad de Salud, Escuela de Enfermería. Bucaramanga, Colombia.

Natalia Esquivel Garzón, Universidad Industrial de Santander. Facultad de Salud, Escuela de Enfermería

PhD. Professional nurse with specialization in Pedagogy and Critical Care in adults. PhD in Nursing. Universidad Industrial de Santander, Facultad de Salud, Escuela de Enfermería. Bucaramanga, Colombia

Dora Inés Parra, Universidad Industrial de Santander. Facultad de Salud, Escuela de Enfermería

PhD. Professional nurse with specialization in Emergency and Disaster Care and Senior Management. Master in Nursing. PhD in Clinical and Community Nursing. Universidad Industrial de Santander, Facultad de Salud, Escuela de Enfermería. Bucaramanga, Colombia. Address Cra. 32 #29-31, Bucaramanga, Santander. Email: doiparra@uis.edu.co; doraiparra@yahoo.com

References

1. Ozger HS, Yasar M, Başyurt R, Bucak F, Dizbay M. Evaluation of the risk factors on time to phlebitis- and nonphlebitis-related failure when peripheral venous catheters were replaced as clinically indicated. The Journal of Vascular Access. 2021;22(1): 69–74. https://doi.org/10.1177/1129729820924553

2. Marsh N, Larsen EN, Ullman AJ, Mihala G, Cooke M, Chopra V, et al. Peripheral intravenous catheter infection and failure: A systematic review and meta-analysis. International Journal of Nursing Studies. 2024;151: 104673. https://doi.org/10.1016/j.ijnurstu.2023.104673

3. Piekiełko P, Mucha A, Stawowczyk E, Wójkowska-Mach J. Peripheral Intravenous Therapy in Internal Medicine Department—Antibiotics and Other Drugs’ Consumption and Characteristics of Vascular Access Devices in 2-Year Observation Study. Antibiotics. 2024;13(7): 664. https://doi.org/10.3390/antibiotics13070664

4. Larsen EN, Marsh N, O’Brien C, Monteagle E, Friese C, Rickard CM. Inherent and modifiable risk factors for peripheral venous catheter failure during cancer treatment: a prospective cohort study. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer. 2021;29(3): 1487–1496. https://doi.org/10.1007/s00520-020-05643-2

5. Chen Y mei, Fan X wen, Liu M hong, Wang J, Yang Y qun, Su Y fang. Risk factors for peripheral venous catheter failure: A prospective cohort study of 5345 patients. The Journal of Vascular Access. 2022;23(6): 911–921. https://doi.org/10.1177/11297298211015035

6. Marsh N, Larsen EN, Takashima M, Kleidon T, Keogh S, Ullman AJ, et al. Peripheral intravenous catheter failure: A secondary analysis of risks from 11,830 catheters. International Journal of Nursing Studies. 2021;124: 104095. https://doi.org/10.1016/j.ijnurstu.2021.104095

7. Garcia-Expósito J, Sánchez-Meca J, Almenta-Saavedra JA, Llubes-Arrià L, Torné-Ruiz A, Roca J. Peripheral venous catheter-related phlebitis: A meta-analysis of topical treatment. Nursing Open. 2023;10(3): 1270–1280. https://doi.org/10.1002/nop2.1449

8. Vendramim P, Avelar AFM, Rickard CM, Pedreira M d. LG. The RESPECT trial–Replacement of peripheral intravenous catheters according to clinical reasons or every 96 hours: A randomized, controlled, non-inferiority trial. International Journal of Nursing Studies. 2020;107: 103504. https://doi.org/10.1016/j.ijnurstu.2019.103504

9. Shimoni Z, Houdhoud N, Isaacs Y, Froom P. Observational study of peripheral intravenous catheter outcomes in an internal medicine department. Internal Medicine Journal. 2023;53(2): 221–227. https://doi.org/10.1111/imj.15963

10.Simões AMN, Vendramim P, Pedreira MLG. Risk factors for peripheral intravenous catheter-related phlebitis in adult patients. Revista da Escola de Enfermagem da USP. 2022;56: e20210398. https://doi.org/10.1590/1980-220X-REEUSP-2021-0398en

11. Liu C, Chen L, Kong D, Lyu F, Luan L, Yang L. Incidence, risk factors and medical cost of peripheral intravenous catheter-related complications in hospitalised adult patients. The Journal of Vascular Access. 2022;23(1): 57–66. https://doi.org/10.1177/1129729820978124

12. Lulie M, Tadesse A, Tsegaye T, Yesuf T, Silamsaw M. Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar hospital, Northwest Ethiopia: a prospective, observational study. Thrombosis Journal. 2021;19(1): 48. https://doi.org/10.1186/s12959-021-00301-x

13. Bashir N, Tanveer H. Incidence and associated risk factors of phlebitis among patients with peripheral intravenous cannula. EPH - International Journal of Medical and Health Science ISSN (Online): 2208-2204. 2024;10(03): 39;45. https://eijmhs.com/index.php/mhs/article/view/239/318

14. Bayeh TL, Birhie AY, Alene EM. Time to Develop Phlebitis and Its Predictors Among Patients with Peripheral Intravenous Cannula at Public Hospitals of Bahir Dar City, Amhara, Ethiopia, 2022: A Prospective Observational Study. Nursing: Research and Reviews. 2023;13: 51–60. https://doi.org/10.2147/NRR.S414331

15. Lv L, Zhang J. The incidence and risk of infusion phlebitis with peripheral intravenous catheters: A meta-analysis. The Journal of Vascular Access. 2020;21(3): 342–349. https://doi.org/10.1177/1129729819877323

16. Cernuda-Martínez JA, Cobo-Sánchez JL, Alarcón-Duque EM, Moreno-Rubio E, Suárez-Mier MB, Del Río-Pisabarro MDC, et al. Clinical-epidemiological predictors of phlebitis associated with peripheral intravenous catheters in Spanish hospitals: results of a national cohort study. International Journal of Nursing Studies Advances. 2025;9: 100355. https://doi.org/10.1016/j.ijnsa.2025.100355

17. Silva-dos Santos T, Candido-Anacleto J, Spinazola-Cesar V, Bressani-Lino RL, de Assunção-Lino A, Garbuio DC, et al. Incidencia de flebitis y factores relacionados en el acceso venoso periférico en adultos. Enfermería Global. 2024;23(74): 26–58. https://doi.org/10.6018/eglobal.587911

18. Khalid Mahmood Mahmood A, Cihan Erdogan B. Peripheral intravenous catheter related phlebitis: A point prevalence study in Iraq. The Journal of Vascular Access. 2025; 11297298251330946. https://doi.org/10.1177/11297298251330946

19. Chen Y mei, Fan X wen, Liu M hong, Wang J, Yang Y qun, Su Y fang. Risk factors for peripheral venous catheter failure: A prospective cohort study of 5345 patients. The Journal of Vascular Access. 2022;23(6): 911–921. https://doi.org/10.1177/11297298211015035

20. Yasuda H, Rickard CM, Marsh N, Yamamoto R, Kotani Y, Kishihara Y, et al. Risk factors for peripheral intravascular catheter-related phlebitis in critically ill patients: analysis of 3429 catheters from 23 Japanese intensive care units. Annals of Intensive Care. 2022;12(1): 33. https://doi.org/10.1186/s13613-022-01009-5

21. Fan XW, Xu L, Wei WS, Chen YM, Yang YQ. Relationship between indwelling site and peripheral venous catheter-related complications in adult hospitalized patients: A systematic review and meta-analysis. Journal of Clinical Nursing. 2023;32(7–8): 1014–1024. https://doi.org/10.1111/jocn.16241

22. Kaplan F, Çelik H, Aslan H, Aktura SÇ. Comparison of peripheral intravenous catheterization applied to different anatomical sites in terms of pain, phlebitis and infiltration. BMC Nursing. 2025;24(1): 393. https://doi.org/10.1186/s12912-025-02979-0

23. Harris V, Hughes M, Roberts R, Dolan G, Williams EM. The Development and Testing of a Chemotherapy-Induced Phlebitis Severity (CIPS) Scale for Patients Receiving Anthracycline Chemotherapy for Breast Cancer. Journal of Clinical Medicine. 2020;9(3): 701. https://doi.org/10.3390/jcm9030701

24. Brørs G, Gjeilo KH, Lund T, Skevik K, Aa E, Høvik LH, et al. Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline. European Journal of Cardiovascular Nursing. 2023;22(8): 824–831. https://doi.org/10.1093/eurjcn/zvad003

25. Lulie M, Tadesse A, Tsegaye T, Yesuf T, Silamsaw M. Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to University of Gondar hospital, Northwest Ethiopia: a prospective, observational study. Thrombosis Journal. 2021;19(1): 48. https://doi.org/10.1186/s12959-021-00301-x

26. Larsen EN, Marsh N, Mihala G, King M, Zunk M, Ullman AJ, et al. Intravenous antimicrobial administration through peripheral venous catheters - establishing risk profiles from an analysis of 5252 devices. International Journal of Antimicrobial Agents. 2022;59(4): 106552. https://doi.org/10.1016/j.ijantimicag.2022.106552

27.Simões AMN, Vendramim P, Pedreira MLG. Risk factors for peripheral intravenous catheter-related phlebitis in adult patients. Revista Da Escola De Enfermagem Da U S P. 2022;56: e20210398. https://doi.org/10.1590/1980-220X-REEUSP-2021-0398en

28. Marsh N, Webster J, Ullman AJ, Mihala G, Cooke M, Chopra V, et al. Peripheral intravenous catheter non-infectious complications in adults: A systematic review and meta-analysis. Journal of Advanced Nursing. 2020;76(12): 3346–3362. https://doi.org/10.1111/jan.14565

29. Mihala G, Ray-Barruel G, Chopra V, Webster J, Wallis M, Marsh N, et al. Phlebitis Signs and Symptoms With Peripheral Intravenous Catheters: Incidence and Correlation Study. Journal of Infusion Nursing: The Official Publication of the Infusion Nurses Society. 2018;41(4): 260–263. https://doi.org/10.1097/NAN.0000000000000288

30. Indriani R, Mediani HS. Effect of the Phlebitis Assessment Scale on the Incidence of Phlebitis Rate on Peripheral Infusion: A Systematic Review. Asian Community Health Nursing Research. 2021; 8–8. https://doi.org/10.29253/achnr.2021.3740

31. Torné-Ruiz A, Reguant M, Sanromà-Ortiz M, Piriz M, Roca J, García-Expósito J. Assessment, Treatment, and Follow-Up of Phlebitis Related to Peripheral Venous Catheterisation: A Delphi Study in Spain. Healthcare (Basel, Switzerland). 2024;12(3): 378. https://doi.org/10.3390/healthcare12030378

32. Nickel B, Gorski L, Kleidon T, Kyes A, DeVries M, Keogh S, et al. Infusion Therapy Standards of Practice, 9th Edition. Journal of Infusion Nursing: The Official Publication of the Infusion Nurses Society. 2024;47(1S Suppl 1): S1–S285. https://doi.org/10.1097/NAN.0000000000000532

33. Jørgensen R, Laursen CB, Konge L, Pietersen PI. Education in the placement of ultrasound-guided peripheral venous catheters: a systematic review. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2021;29: 83. https://doi.org/10.1186/s13049-021-00897-z

34. Ventura D, DaSilva Freitas J, Simoes J. Inclusion of the European Portuguese Version of the Visual Infusion Phlebitis Scale in a Health Information System | HIMSS. Online Journal of Nursing Informatics (OJNI):26 (3). [Accessed 19th September 2025] https://legacy.himss.org/resources/inclusion-european-portuguese-version-visual-infusion-phlebitis-scale-health-information

35. Kuş B, Büyükyılmaz F. Görsel İnfüzyon Flebit Tanılama Skalası: Bağımsız Gözlemciler Arası Uyum Çalışması. Florence Nightingale Journal of Nursing. 2018;26(3): 179–186. https://dergipark.org.tr/tr/pub/fnjn/issue/39968/296258

36. Marimuthu M, Muniasmy M, Barathiraja B, Venkatesh V. Visual Infusion Phlebitis (VIP) score for assessing venflon-related complications: a prospective observational study. International Journal of Advanced Research. 2024;12(12): 1239–1242. https://doi.org/10.21474/IJAR01/20134

37. O’Donnell C, Fardanesh A, Bakare O, Spiteri A, Dewan L, Rohatgi A. 544 The VIP QIP - Reducing the Rate of Inpatient Phlebitis. BJS. 2024;111(Supplement_6): znae163.244. https://doi.org/10.1093/bjs/znae163.244

38. Marsh N, Mihala G, Ray‐Barruel G, Webster J, Wallis MC, Rickard CM. Inter‐rater agreement on PIVC ‐associated phlebitis signs, symptoms and scales. Journal of Evaluation in Clinical Practice. 2015;21(5): 893–899. https://doi.org/10.1111/jep.12396

39. Walker RM, Pires MPO, Ray-Barruel G, Cooke M, Mihala G, Azevedo SS, et al. Peripheral vascular catheter use in Latin America (the vascular study): A multinational cross-sectional study. Frontiers in Medicine. 2023;9: 1039232. https://doi.org/10.3389/fmed.2022.1039232

Published
08-05-2026
How to Cite
[1]
Rojas, L.Z. et al. 2026. Interrater agreement of the classification of phlebitis, its signs, and symptoms in peripheral intravenous catheters. Global Nursing. 25, 1 (May 2026). DOI:https://doi.org/10.6018/eglobal.659521.
Issue
Section
ORIGINAL RESEARCH